NEXGEL, Inc. (NXGL) Research

NEXGEL, Inc. is a company that develops and produces advanced hydrogels and gels. These materials are characterized by their significant water content, aqueous polymer composition, and electron beam cross-linking technology. NEXGEL's diverse product range serves crucial applications across several sectors, including wound care management, medical diagnostic tools, transdermal drug delivery systems, and cosmetic formulations. The company was founded in 1997 and operated under the name AquaMed Technologies, Inc. until it rebranded as NEXGEL, Inc. in November 2019. Its headquarters are located in Langhorne, Pennsylvania.

Market snapshot

Symbol
NXGL
Price
$0.57
Day change
-7.36%
Market cap
$5.2M
P/E ratio
-1.44x
52-week range
0.481-2.89
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Next earnings
in 2 months

Peer companies

  • Enlivex Therapeutics Ltd. (ENLV)
  • Femasys Inc. (FEMY)
  • CytoMed Therapeutics Limited (GDTC)
  • Harvard Bioscience, Inc. (HBIO)
  • Inspira Technologies Oxy B.H.N. Ltd. (IINN)
  • Milestone Scientific Inc. (MLSS)
  • MetaVia Inc. (MTVA)
  • Nexalin Technology, Inc. (NXL)

Recent insider activity

  • Levy Adam R. — S-Sale (3000 shares) on 2026-06-11
  • Levy Adam R. — S-Sale (3000 shares) on 2026-06-04
  • Levy Adam R. — S-Sale (3000 shares) on 2026-06-08
  • Levy Adam R. — S-Sale (2000 shares) on 2026-06-01
  • Levy Adam R. — S-Sale (3000 shares) on 2026-05-27

Open NEXGEL, Inc. (NXGL) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.